Richard Appleyard

Richard Appleyard

Auto-generated profile, based on publicly available information

Richard Appleyard

Macquarie University Translational Orthopaedic Research Laboratory (MQ TOR Lab), Faculty of Medicine, Health and Human Sciences Macquarie University New South Wales Australia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in Bone
Verified
Journal Article
Closed access
HNH Namkung-Matthai
H Namkung-Matthai
RAR Appleyard
R Appleyard
JJJ Jansen
J Jansen
JLJ Hao Lin
J Hao Lin
SMS Maastricht
S Maastricht
TDT Diamond
T Diamond

1 July 2010 in Biomaterials
Verified
Journal Article
Closed access
SRSeyed-Iman Roohani-Esfahani
Seyed-Iman Roohani-Esfahani
SNSaied Nouri-Khorasani
Saied Nouri-Khorasani
Zufu  LuZufu Lu
Zufu Lu
RARichard Appleyard
Richard Appleyard
HZHala Zreiqat
Hala Zreiqat

7 May 2008 in British Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
MSMya Lay Sein
Mya Lay Sein
JWJudie Walton
Judie Walton
JLJames Linklater
James Linklater
RARichard Appleyard
Richard Appleyard
BKBrent Kirkbride
Brent Kirkbride
GMGeorge A C Murrell
George A C Murrell
Background/hypothesis: Shoulder pain in elite swimmers is common, and its pathogenesis is uncertain.Hypothesis/study design: The authors used a crosssectional study design to test Jobe’s hypothesis that repetitive forceful swimming leads to shoulder laxity, which in turn leads to impingement pain.Methods: Eighty young elite swimmers (13–25 years of age) completed questionnaires on their swimming training, pain and shoulder function. They were given a standardised clinical shoulder examination, and tested for glenohumeral joint laxity using a non-invasive electronic laxometer. 52/80 swimmers also attended for shoulder MRI.Results: 73/80 (91%) swimmers reported shoulder pain. Most (84%) had a positive impingement sign, and 69% of those examined with MRI had supraspinatus tendinopathy. The impingement sign and MRIdetermined supraspinatus tendinopathy correlated strongly (rs=0.49, p<0.00001). Increased tendon thickness correlated with supraspinatus tendinopathy (rs=0.37, p<0.01). Laxity correlated weakly with impingement pain (rs=0.23, p<0.05) and was not associated with supraspinatus tendinopathy (rs=0.14, p=0.32). The number of hours swum/week (rs=0.39, p<0.005) and weekly mileage (rs=0.34, p=0.01) both correlated significantly with supraspinatus tendinopathy. Swimming stroke preference did not.Conclusions: These data indicate: (1) supraspinatus tendinopathy is the major cause of shoulder pain in elite swimmers; (2) this tendinopathy is induced by large amounts of swimming training; and (3) shoulder laxity per se has only a minimal association with shoulder impingement in elite swimmers. These findings are consistent with animal and tissue culture findings which support an alternate hypothesis: the intensity and duration of load to tendon fibres and cells cause tendinopathy, impingement and shoulder pain.

1 April 2009 in Biomaterials
Verified
Journal Article
Closed access
CWChengtie Wu
Chengtie Wu
YRYogambha Ramaswamy
Yogambha Ramaswamy
YZYufang Zhu
Yufang Zhu
RZRongkun Zheng
Rongkun Zheng
RARichard Appleyard
Richard Appleyard
HZHala Zreiqat
Hala Zreiqat

1 May 2004 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JPJustin A. Paoloni
Justin A. Paoloni
RARichard C. Appleyard
Richard C. Appleyard
JNJanis Nelson
Janis Nelson
GMGeorge A.C. Murrell
George A.C. Murrell
Noninsertional Achilles tendinopathy is a degenerative overuse disorder. No method has been universally successful in treating this condition. Topically applied nitric oxide has been shown, in animal models, to be effective for the treatment of fractures and cutaneous wounds through mechanisms that may include stimulation of collagen synthesis in fibroblasts. The goal of the present study was to determine if topical glyceryl trinitrate improves clinical outcome measures in patients with Achilles tendinopathy. A prospective, randomized, double-blind, placebo-controlled trial involving a total of sixty-five patients (eighty-four Achilles tendons) was performed to compare continuous application of topical glyceryl trinitrate (at a dosage of 1.25 mg per twenty-four hours) with rehabilitation alone for the treatment of noninsertional Achilles tendinopathy. Compared with the control group, the glyceryl trinitrate group showed reduced pain with activity at twelve weeks (p = 0.02) and twenty-four weeks (p = 0.03), reduced night pain at twelve weeks (p = 0.04), reduced tenderness at twelve weeks (p = 0.02), decreased pain scores after the hop test at twenty-four weeks (p = 0.005), and increased ankle plantar flexor mean total work compared with the baseline level at twenty-four weeks (p = 0.04). Twenty-eight (78%) of thirty-six tendons in the glyceryl trinitrate group were asymptomatic with activities of daily living at six months, compared with twenty (49%) of forty-one tendons in the placebo group (p = 0.001, chi-square analysis). The mean effect size for all outcome measures was 0.14. Topical glyceryl trinitrate significantly reduced pain with activity and at night, improved functional measures, and improved outcomes in patients with Achilles tendinopathy. Therapeutic study, Level I-1a (randomized controlled trial [significant difference]). See Instructions to Authors for a complete description of levels of evidence.

1 November 2003 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
JPJustin A. Paoloni
Justin A. Paoloni
RARichard C. Appleyard
Richard C. Appleyard
JNJanis Nelson
Janis Nelson
GMGeorge A. C. Murrell
George A. C. Murrell
Background: Extensor tendinosis (“tennis elbow”) is a degenerative overuse tendinopathy of the wrist extensors at their attachment to the lateral humeral epicondyle. No treatment has been universally successful. Topical application of nitric oxide has been used effectively to treat fractures and cutaneous wounds in animal models, presumably by stimulation of collagen synthesis in fibroblasts. Purpose: To determine whether topical nitric oxide can improve outcome of patients with extensor tendinosis. Study Design: Prospective, randomized, double-blinded clinical trial. Methods: Eighty-six patients with extensor tendinosis were randomized into two equal groups; both were instructed to perform a standard tendon rehabilitation program. One group received an active glyceryl trinitrate transdermal patch, and the other group received a placebo patch. Results: Patients in the glyceryl trinitrate group had significantly reduced elbow pain with activity at 2 weeks, reduced epicondylar tenderness at 6 and 12 weeks, and an increase in wrist extensor mean peak force and total work at 24 weeks. At 6 months, 81% of treated patients were asymptomatic during activities of daily living, compared with 60% of patients who had tendon rehabilitation alone. Conclusions: Application of topical nitric oxide improved early pain with activity, late functional measures, and outcomes of patients with extensor tendinosis.